Describing Patient With DME, Their Patient Journey and Disease Progression

Boehringer Ingelheim

Status: Completed

Conditions: Diabetic Macular Edema

Study type: Observational

Funder types: Industry

Identifiers

NCT05966753

1485-0016

Details and patient eligibility

About

This study aims to characterize patients with diabetic macular edema (DME), their progression, the treatment received and associate the functional and physiological outcomes related to the treatment.

Enrollment: 221,004 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

All patients ≥18 years, with a DME diagnosis in at least one eye, included in the Vestrum database identified during the study period (January 2015 to April 2023)

Exclusion criteria

Patients without the information of laterality will be excluded.

Trial design

221,004 participants in 1 patient group

Patients with diabetic macula edema (DME)

Description:

Patients diagnosed with diabetic macula edema (DME) in at least one eye, at least 18 years old, with information on laterality and registered in the Vestrum health database between January 2015 and May 2023.